Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statements of Changes in Shareholders Equity

v3.24.1.u1
Interim Consolidated Statements of Changes in Shareholders Equity - USD ($)
Total
Share Capital [Member]
Contributed Surplus [Member]
Accumulated other comprehensive Income [Member]
Accumulated Deficit [Member]
Balance, shares at Dec. 31, 2022   224,699,621      
Balance, amount at Dec. 31, 2022 $ 62,499,000 $ 258,646,000 $ 19,843,000 $ 4,265,000 $ (220,255,000)
Exercise of stock options, shares   536,183      
Exercise of stock options, amount 298,000 $ 429,000 (131,000) 0 0
Shares issued for cash, shares   39,491,000      
Shares issued for cash, amount 37,528,000 $ 37,528,000 0 0 0
Share issue costs (2,992,000) (2,992,000) 0 0 0
Stock compensation 253,000 0 253,000 0 0
Comprehensive loss (1,030,000) $ 0 0 (317) (713,000)
Balance, shares at Mar. 31, 2023   264,726,804      
Balance, amount at Mar. 31, 2023 96,556,000 $ 293,611,000 19,965,000 3,948,000 (220,968,000)
Balance, shares at Dec. 31, 2023   270,898,900      
Balance, amount at Dec. 31, 2023 74,870,000 $ 302,182,000 19,881,000 3,718,000 (250,911,000)
Exercise of stock options, shares   74,674      
Exercise of stock options, amount 40,000 $ 61,000 (21,000) 0 0
Shares issued for cash, shares   2,464,500      
Shares issued for cash, amount 4,227,000 $ 4,227,000 0 0 0
Share issue costs (106,000) (106,000) 0 0 0
Stock compensation 324,000 0 324,000 0 0
Comprehensive loss (18,258,000) $ 0 0 283,000 (18,541,000)
Exercise of warrants, shares   8,188,250      
Exercise of warrants, amount 15,849,000 $ 15,849,000 0 0 0
Balance, shares at Mar. 31, 2024   281,626,324      
Balance, amount at Mar. 31, 2024 $ 76,946,000 $ 322,213,000 $ 20,184,000 $ 4,001,000 $ (269,452,000)